SCHEMBL23286161

SCHEMBL23286161

COC(=O)c1ccc(N)c(NCC2(C)CC2)n1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.35
MAPT P10636 4/20 0.35
KDM4E B2RXH2 3/20 0.35
GAA P10253 3/20 0.35
HSD17B10 Q99714 2/20 0.35
HPGD P15428 1/20 0.35
ALOX15 P16050 1/20 0.35
TSHR P16473 1/20 0.35
MAPK1 P28482 1/20 0.35
CYP1A2 P05177 2/20 0.35
NPC1 O15118 1/20 0.35
TP53 P04637 1/20 0.35
CYP3A4 P08684 1/20 0.35
CYP2C9 P11712 1/20 0.35
CYP2C19 P33261 1/20 0.35
RAB9A P51151 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
PTGER4 P35408 1/20 0.34
BDKRB1 P46663 1/20 0.34
PKM P14618 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23703569 0.85 PTGER4 (0.34) ALDH1A1MAPTKDM4EGAAHSD17B10
SCHEMBL23767816 0.84 KCNH2 (0.32) ALDH1A1MAPTKDM4EGAAHSD17B10
SCHEMBL23703943 0.82 JAK2 (0.35) ALDH1A1MAPTKDM4EGAAHSD17B10
SCHEMBL31463457 0.82 JAK2 (0.35) ALDH1A1MAPTKDM4EGAAHSD17B10
SCHEMBL23767637 0.78 PTGER4 (0.48) ALDH1A1MAPTKDM4EGAAHSD17B10
SCHEMBL23286239 0.78 PTGER4 (0.44) ALDH1A1MAPTKDM4EGAAHSD17B10
SCHEMBL23753892 0.77 ALDH1A1 (0.36) ALDH1A1MAPTKDM4EGAAHSD17B10
SCHEMBL20288051 0.74 KMT2A (0.38) ALDH1A1MAPTKDM4EGAAHSD17B10
SCHEMBL20279929 0.74 KMT2A (0.38) ALDH1A1MAPTKDM4EGAAHSD17B10
SCHEMBL30538768 0.74 KMT2A (0.38) ALDH1A1MAPTKDM4EGAAHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11702404-B2 GLP-1R modulating compounds GILEAD SCIENCES, INC. (US) 2023-07-18 US disclosed
US-11702404-B2 GLP-1R modulating compounds GILEAD SCIENCES, INC. (US) 2023-07-18 US disclosed
CN-114630823-A GLP-1R modulating compounds 吉利德科学公司 2022-06-14 CN disclosed
US-20210171499-A1 GLP-1R MODULATING COMPOUNDS GILEAD SCIENCES, INC. 2021-06-10 US disclosed
WO-2021081207-A1 GLP-1R MODULATING COMPOUNDS GILEAD SCIENCES, INC. (US) 2021-04-29 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11702404-B2 GLP-1R modulating compounds GLP1R, GIPR, GPR119 ALDH1A1 3556/4885MAPT 3314/4885KDM4E 2322/4885
US-20210171499-A1 GLP-1R MODULATING COMPOUNDS GLP1R, GIPR, GPR119 ALDH1A1 3556/4885MAPT 3314/4885KDM4E 2322/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.